Inventor · disambiguated record
Andrea Alimonti
Also filed as: ALIMONTI ANDREA
5 granted patents·5 pending applications·1 citations·filing 2014–2022
61Inventor score
Top patents by PatentIndex Score
10 records- 0164US11168134B2Methods of treating androgen deprivation therapy resistant prostate cancerFOND PER LISTITUTO ONCOLOGICO DI RICERCA IOR·Filed 2019·Granted Nov 9, 2021·1 cites·9 claims
- 0263US12337022B2Use of a vegetable extract from salvia haenkei as an active agent in the treatment of heart diseasesALTERGON SA·Filed 2022·Granted Jun 24, 2025·0 cites·11 claims
- 0357US2024285711A1Use of a vegetal extract from salvia haenkei as an active agent in the treatment of a musculoskeletal disorderALTERGON SA·Filed 2022·Application pending·0 cites
- 0452US9668961B2Screening method and substances for contrasting agingALIMONTI ANDREA·Filed 2014·Granted Jun 6, 2017·0 cites·6 claims
- 0546US11235017B2Use of a vegetable extract as an active agent in the treatment of dermatological diseasesALTERGON SA·Filed 2018·Granted Feb 1, 2022·0 cites·10 claims
- 0646US11235016B2Use of a vegetal extract as an active agent in tissue re-epithelizing and cicatrizing processesALTERGON SA·Filed 2018·Granted Feb 1, 2022·0 cites·9 claims
- 0743US2025268958A1Commensal bacteria promote endocrine-resistance in prostate cancer via androgen biosynthesisFOND PER LISTITUTO ONCOLOGICO DI RICERCA IOR·Filed 2022·Application pending·0 cites
- 0840US2022143051A1Compositions and methods of use comprising substances with neural plasticity actions administered at non-psychedelic/psychotomimetic dosages and formulationsArbormentis LLC·Filed 2020·Application pending·0 cites
- 0939US2020405727A1New alk inhibitor senolytic drugsFOND PER LISTITUTO ONCOLOGICO DI RICERCA IOR·Filed 2019·Application pending·0 cites
- 1038US2023174662A1Methods of treating castrate-resistant prostate cancerFOND PER LISTITUTO ONCOLOGICO DI RICERCA IOR·Filed 2020·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →